Patrick J. Christmas - 02 Jan 2025 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Signature
/s/ Patrick J. Christmas
Issuer symbol
RGNX
Transactions as of
02 Jan 2025
Net transactions value
-$88,083
Form type
4
Filing time
06 Jan 2025, 16:59:08 UTC
Previous filing
05 Aug 2024
Next filing
04 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Tax liability $88,083 -11,395 -6.6% $7.73 160,810 02 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Options (Right to buy) Award $0 +223,350 $0.000000 223,350 02 Jan 2025 Common Stock 223,350 $7.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024.
F2 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.